Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1431
  • Home
  • Print this page
  • Email this page

   Table of Contents      
Year : 2015  |  Volume : 63  |  Issue : 2  |  Page : 91

Ocular oncology - A multidisciplinary specialty

Editor, Indian Journal of Ophthalmology, Chairman, Managing Director, Aditya Jyot Eye Hospital Pvt. Ltd., Wadala (W), Mumbai, Maharashtra, India

Date of Web Publication1-Apr-2015

Correspondence Address:
Sundaram Natarajan
Editor, Indian Journal of Ophthalmology, Chairman, Managing Director, Aditya Jyot Eye Hospital Pvt. Ltd., Wadala (W), Mumbai, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0301-4738.154364

Rights and Permissions

How to cite this article:
Natarajan S. Ocular oncology - A multidisciplinary specialty. Indian J Ophthalmol 2015;63:91

How to cite this URL:
Natarajan S. Ocular oncology - A multidisciplinary specialty. Indian J Ophthalmol [serial online] 2015 [cited 2020 May 31];63:91. Available from: http://www.ijo.in/text.asp?2015/63/2/91/154364

Dear Friends,

It has been my endeavor to bring to our readers a wide array of articles from authors of eminence in their field. This issue is dedicated to a specialized field still evolving rapidly. Unlike any other sub-specialty of ophthalmology, ocular oncology is unique. Ocular oncology involves not just the oncologist but a team of highly specialized physicians - ophthalmologists, radiologists, medical, and radiation oncologists. Often times, ocular tumors require radical treatment in the form of mutilating surgeries which later require cosmetic rehabilitation; thus, requiring the expertise of ocularists as well.

Tumors of the eye may be diverse and varied in their clinical presentation. Equally diverse are the diagnostic modalities and treatment options for them. In the 1980s and early 1990s, all that was available for retinoblastoma was radiation and radical surgery like enucleation. From those days, treatment has evolved today to become not only more effective but also have minimal collateral damage and systemic side-effects. Treatment of retinoblastoma has progressed with the aim of treatment no longer being "life salvage." Today, the aim is "globe salvage" or even "vision salvage" in retinoblastomas; more of which Kaliki et al. have discussed in detail this issue. Selective intra-arterial chemotherapy, intravitreal chemotherapy, neo-adjuvant chemotherapy, and plaque brachytherapy are some of the newer advances in the field of ocular oncology. [1],[2],[3],[4] The treatment of uveal melanoma too has changed - newer reports of endo-resection in cases of choroidal melanoma are indicative that surgery may still be an option. [5]

Carol and Jerry Shields in their article, "trends in the management of intraocular tumors over 40 years" have very eloquently captured the evolution of treatment options and increasingly improving outcomes in the management of intraocular tumors. In this issue, Rishi et al. have discussed the use of radiological, molecular, and cytological features of uveal melanoma in enhancing the accuracy of early diagnosis and improved prognosis.

While this issue largely focuses on intraocular oncology, we hope to publish, in the future articles and issues on orbital and ocular surface tumors as well.

Evidence-based data are not abundant in ophthalmic oncology; this issue was envisaged and compiled with the purpose of bringing together relevant original articles that reflect current research in ocular oncology as well as clinical pearls from experience of specialists who have dedicated years in his field. In continuation of the theme of ocular oncology, the next issue of the Indian Journal of Ophthalmology will have more articles by accomplished ocular oncologists Helen Dimaris, Lingam Gopal and Santosh Honavar. I am grateful to Dr Vikas Khetan for taking the initiative in putting together this issue as the Guest Editor and bringing a wonderful compilation for your reading.

Happy Reading !

  References Top

Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115:1398-404, e1.  Back to cited text no. 1
Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: From prohibition to conditional indications. Br J Ophthalmol 2012;96:1078-83.  Back to cited text no. 2
Kaliki S, Ayyar A, Nair AG, Mishra DK, Reddy VA, Naik MN. Neoadjuvant systemic chemotherapy in the management of extensive eyelid sebaceous gland carcinoma: A study of 10 cases. Ophthal Plast Reconstr Surg 2015; [Epub ahead of print].  Back to cited text no. 3
Sagoo MS, Shields CL, Mashayekhi A, Freire J, Emrich J, Reiff J, et al. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma). Arch Ophthalmol 2007;125:1202-9.  Back to cited text no. 4
Caminal JM, Mejia K, Masuet-Aumatell C, Arias L, Piulats JM, Gutierrez C, et al. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmol 2013;156:334-42.e1.  Back to cited text no. 5


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded298    
    Comments [Add]    

Recommend this journal